| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Abramson HA, Evans LT, Ge... |
Bioassays for LSD-25 |
Annual Rep. Biol. La... |
1954 |
| Monnier M, Tissot R |
L'action de la réserpine-sérotonine sur le cerveau; suppression par le... |
Schweiz. Arch. Neur... |
1958 |
| Naranjo P |
Drogas psicotomiméticas. Estudio comparativo de la harmina, la dietil... |
Arch. criminol. neur... |
1958 |
| Tedeschi DH, Tedeschi RE,... |
The effects of tryptamine on the central nervous system, including a p... |
J.Pharmacol.Exper.Th... |
1959 |
| Delay J, Pichot P, Lempér... |
Les effets somatiques de la Psilocybine |
Presse méd. |
1959 |
| Monnier M |
Action de la Psilocybine sur le cerveau du lapin |
Experientia |
1959 |
| Monnier M, Krupp P |
Classification électro-physiologique des stimulants du système nerveux... |
Arch. Int. Pharmacod... |
1960 |
| Kelly PH |
Action of LSD on supersensitive mesolimic dopamine receptors |
British J.Pharmac. |
1975 |
| Maj J |
The influence of dopaminergic agents on the serotoninergic neurons |
Pol J Pharmacol Phar... |
1975 |
| Bignami G |
Nonassociative Explanations Of Behavioral Changes Induced By Central C... |
Acta. Nuerobiol. exp... |
1976 |
| Horowski R, Wachtel H |
Direct Dopaminergic Action Of Lisuride Hydrogen Maleate, An Ergot Deri... |
European Journal of ... |
1976 |
| Arushanyan EB |
The Mesolimbic System of the Brain and its Participation in the Action... |
Farmakol. i Toksikol... |
1977 |
| Bowers MB |
Psychoses Precipitated by Psychotomimetic Drugs: A Follow-up Study |
Arch.Gen.Psychiat. |
1977 |
| Maj J, Baran L, Rawlow A,... |
Central effects of miaserin and danitracen - New antidepressants of un... |
Pol.J.Pharmacol.Phar... |
1977 |
| Messiha FS |
Dopamine, the Psyche, and Extrapyramidal Disorders |
Clin.Pharmacol.Ther. |
1977 |
| Marquardt GM, DiStefano V... |
Pharmacological and Toxicological Effects of B-3,4-Methylenedioxyamphe... |
Toxicol.Appl.Pharmac... |
1978 |
| Rech RH |
Brain Lesions and Psychostimulant Drugs |
Psychopharmacol.Bull... |
1978 |
| Owman C, Edvinsson L, Har... |
Pharmacological in vitro Analysis of Amine-Mediated Vasomotor Function... |
Blood Vessels |
1978 |
| Layzer RB |
Myeloneuropathy after prolonged exposure to nitrous oxide |
Lancet |
1979 |
| Cannon JG, Perez Z, Long ... |
N-Alkyl derivatives of +/--alpha-methyldopamine |
J Med Chem |
1979 |
| Morgenstern R, Fink H, Oe... |
LSD-Potentiated Apomorphine Hypermotility: A Model for Differentiating... |
Pharmacol.Biochem.Be... |
1983 |
| Siegel RK |
LSD-induced effects in elephants: Comparisons with musth behavior. |
Bulletin of the Psyc... |
1984 |
| Reith ME, Meisler BE, Laj... |
Locomotor effects of cocaine, cocaine congeners, and local anesthetics... |
Pharmacol Biochem Be... |
1985 |
| Freedman DX |
Hallucinogenic drug research--if so, so what? Symposium summary and co... |
Pharmacol Biochem Be... |
1986 |
| Gold LH, Koob GF |
Methysergide potentiates the hyperactivity produced by MDMA in rats |
Pharmacol Biochem Be... |
1988 |
| Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
| Gold LH, Geyer MA, Koob G... |
Psychostimulant properties of MDMA |
NIDA Res Monogr |
1989 |
| Gold LH, Geyer MA, Koob G... |
Neurochemical mechanisms involved in behavioral effects of amphetamine... |
NIDA Res Monogr |
1989 |
| Gold LH, Hubner CB, Koob ... |
A role for the mesolimbic dopamine system in the psychostimulant actio... |
Psychopharmacology (... |
1989 |
| Li AA, Marek GJ, Vosmer G... |
Long-term central 5-HT depletions resulting from repeated administrati... |
Pharmacol Biochem Be... |
1989 |
| Seiden LS, Kleven MS |
Methamphetamine and related drugs: toxicity and resulting behavioral c... |
NIDA Res Monogr |
1989 |
| Paulus MP, Geyer MA, Gold... |
Application of entropy measures derived from the ergodic theory of dyn... |
Proc Natl Acad Sci U... |
1990 |
| Winslow JT, Insel TR |
Serotonergic modulation of the rat pup ultrasonic isolation call: stud... |
Psychopharmacology (... |
1991 |
| Callaway CW, Geyer MA |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... |
Eur J Pharmacol |
1992 |
| Callaway CW, Rempel N, Pe... |
Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced b... |
Neuropsychopharmacol... |
1992 |
| Sarnyai Z, Kovacs GL |
Role of oxytocin in the neuroadaptation to drugs of abuse |
Psychoneuroendocrino... |
1994 |
| Hegadoren KM, Martin-Iver... |
Comparative behavioural and neurochemical studies with a psychomotor s... |
Psychopharmacology (... |
1995 |
| McNamara MG, Kelly JP, Le... |
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methyl... |
Pharmacol Biochem Be... |
1995 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Geyer MA |
Serotonergic functions in arousal and motor activity |
Behav Brain Res |
1996 |
| Dulawa SC, Geyer MA |
Psychopharmacology of prepulse inhibition in mice |
Chin J Physiol |
1996 |
| De Feo V, Capasso A, De ... |
CNS Pharmacological Effects of Aqueous Extract from Iresine Herbstii |
International Journa... |
1996 |
| Matsumoto K, Mizowaki M, ... |
Suppressive effect of mitragynine on the 5-methoxy-N,N-dimethyltryptam... |
Pharmacol Biochem Be... |
1997 |
| Weinmann W, Bohnert M |
Lethal monointoxication by overdosage of MDEA |
Forensic Sci Int |
1998 |
| Decker MW, Bannon AW, Buc... |
Antinociceptive effects of the novel neuronal nicotinic acetylcholine ... |
Eur J Pharmacol |
1998 |
| Laviola G, Adriani W, Ter... |
Psychobiological risk factors for vulnerability to psychostimulants in... |
Neurosci Biobehav Re... |
1999 |
| Erdtmann-Vourliotis M, Ma... |
Prior experience of morphine application alters the c-fos response to ... |
Brain Res Mol Brain ... |
2000 |
| Bankson MB, Cunningham KA |
3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotoni... |
Journal of Pharmacol... |
2001 |
| Young R, Glennon RA |
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinol... |
Pharmacol Biochem Be... |
2002 |
| Won L, Bubula N, Heller A |
Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhance... |
Brain Res Dev Brain ... |
2002 |
| Holden C |
Drug find could give ravers the jitters |
Science |
2002 |
| Benedetti F |
How the doctor's words affect the patient's brain |
Eval Health Prof |
2002 |
| Timar J, Gyarmati S, Szab... |
Behavioural changes in rats treated with a neurotoxic dose regimen of ... |
Behav Pharmacol |
2003 |
| Iravani MM, Jackson MJ, ... |
3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expres... |
The Journal of Neuro... |
2003 |
| Hornung JP |
The human raphe nuclei and the serotonergic system |
J Chem Neuroanat |
2003 |
| Ho YJ, Pawlak CR, Guo L, ... |
Acute and long-term consequences of single MDMA administration in rela... |
Behav Brain Res |
2004 |
| Powell SB, Lehmann-Masten... |
MDMA 'ecstasy' alters hyperactive and perseverative behaviors in dopam... |
Psychopharmacology (... |
2004 |
| Quate L, McBean DE, Ritch... |
Acute methylenedioxymethamphetamine administration: effects on local c... |
Psychopharmacology (... |
2004 |
| Ootsuka Y, Nalivaiko E, B... |
Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outfl... |
Brain Res |
2004 |
| Sala M, Braida D |
Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interact... |
Pharmacol Biochem Be... |
2005 |
| Wittmann M, Carter O, Has... |
Effects of psilocybin on time perception and temporal control of behav... |
J Psychopharmacol |
2006 |
| Williard RL, Middaugh LD,... |
Methylphenidate and its ethanol transesterification metabolite ethylph... |
Behav Pharmacol |
2007 |
| Girard TA, Martius DL, Ch... |
Mental representation of space: insights from an oblique distribution ... |
Neuropsychologia |
2007 |
| Selken J, Nichols DE |
Alpha1-adrenergic receptors mediate the locomotor response to systemic... |
Pharmacol Biochem Be... |
2007 |
| Cochems A, Harding P, Lid... |
Dextromethorphan in Wisconsin drivers |
J Anal Toxicol |
2007 |
| Hooker JM, Xu Y, Schiffer... |
Pharmacokinetics of the potent hallucinogen, salvinorin A in primates ... |
Neuroimage |
2008 |
| Neukamm MA, Mürdter TE, W... |
Quantitative determination of the active ’Spice’ ingredient JWH-018 in... |
|
2008 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Kehr J, Ichinose F, Yoshi... |
Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increa... |
Br J Pharmacol |
2011 |
| Quednow BB, Kometer M, Ge... |
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are... |
Neuropsychopharmacol... |
2012 |
| Salomonsen-Sautel S, Min ... |
Trends in fatal motor vehicle crashes before and after marijuana comme... |
Drug Alcohol Depend |
2014 |
| Wainiqolo I, Kool B, Nosa... |
Is driving under the influence of kava associated with motor vehicle c... |
Aust N Z J Public He... |
2015 |
| Pálenícek T, Lhotková E, ... |
Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmaco... |
Prog Neuropsychophar... |
2016 |
| Wallach J, Kang H, Colest... |
Pharmacological Investigations of the Dissociative 'Legal Highs' Diphe... |
PLoS One |
2016 |
| Ossato A, Bilel S, Gregor... |
Neurological, sensorimotor and cardiorespiratory alterations induced b... |
Neuropharmacology |
2018 |
